SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-189220
Filing Date
2017-05-31
Accepted
2017-05-31 16:03:06
Documents
1
Effectiveness Date
2017-05-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A d386566ddefa14a.htm DEFA14A 17644
  Complete submission text file 0001193125-17-189220.txt   18967
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 17881024
SIC: 2834 Pharmaceutical Preparations